Abstract
Hepatitis C Virus No hepatitis C virus (HCV) vaccine is currently available. Furthermore, evidence from studies in nonhuman primates suggests that any future human HCV vaccine would be unlikely to induce complete immunity. Major et al. examined whether lowered HCV titers potentially resulting from an imperfect vaccine might still stem HCV transmission in people who inject drugs. They measured the HCV RNA from infected human plasma retained in contaminated needles and syringes. Their mathematical model combining these measurements with published data on HCV viral kinetics suggested that a partially effective vaccine could reduce the HCV transmission risk from sharing contaminated needles and syringes. Sci. Transl. Med. 10 , eaao4496 (2018).
Paper version not known (
Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
